1561 - Marco Songini Prevalence of diabetic complications...

Info iconThis preview shows pages 1–12. Sign up to view the full content.

View Full Document Right Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: Marco Songini Prevalence of diabetic complications in relation to demographics in Europe State-of-the-art in reference to published data Part 2: microvascular diseases, neuropathy and costs of diabetes Dr Marco Songini is the director of the Diabetes Unit at S. Michele Hospital in Cagliari (Sardinia-Italy). He is also the vice-president of ASRIS (Association for the Study of Type 1 Diabetes in Sardinia) DM-MED project is aimed to develop recommendations for public health policy in the Mediterranean countries with emphasis on the prediction, prevention and control of Types 1 and 2 diabetes and their complications. The emphasis of this meeting was on description of the health programs of the participating countries, on the epidemiology of diabetes and its complications in the Mediterranean region, and on the need for methodology of diabetes registries. The present is one of the lectures of the DM-MED meeting. Epidemiology of diabetes chronic complications Microvascular diseases Retinopathy in Diabetes in Europe Type 1 diabetes Type 2 diabetes All NE WE EE SE 10 20 30 40 50 60 70 80 90 % Diabet Med, 14 (S1); 1997 Epidemiology of diabetes chronic complications Microvascular diseases Frequency of retinopathy among Eurodiab PCS pts at baseline Proliferative Background 10 20 30 40 50 60 70 % 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 19 20 21 22 23 18 Epidemiology of diabetes chronic complications Microvascular diseases Retinopathy in Type 2 diabetes (UKPDS) 1.03 0.83 0.83 0.79 0.78 0.017 0.012 0.015 0 - 3 years 0 - 6 years 0 - 9 years 0 - 12 years RR p 0.5 1 2 Relative Risk & 99% CI Favour s conventional therapy(2) Favours intensive therapy(1) Epidemiology of diabetes chronic complications Microvascular diseases Retinopathy in Type 2 diabetes (UKPDS) 243 461 207 411 152 300 20 40 60 % patients 3 years 6 years 9 years p=0.38 p=0.019 p=0.004 Years from randomisation- TC- LTC Epidemiology of diabetes chronic complications Microvascular diseases Nephropathy in Diabetes in Europe Type 1 diabetes Type 2 diabetes All NE WE EE SE 5 10 15 20 % Diabet Med, 14 (S1); 1997 Epidemiology of diabetes chronic complications Microvascular diseases Frequency of nephropathy (albuminuria) among Eurodiab PCS pts at baseline 10 20 30 40 50 % macroalbumin uria microalbumin uria 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Epidemiology of diabetes chronic complications Microvascular diseases Risk of albuminuria among Eurodiab PCS pts 10 20 30 40 50 60 microalbuminuria at baseline (351 pts) normoalbuminuria at baseline (1,134 pts) Progression to micro Progression to macro Regression to normo % 13% 2 % 14 % 51 % Epidemiology of diabetes chronic complications Microvascular diseases...
View Full Document

Page1 / 27

1561 - Marco Songini Prevalence of diabetic complications...

This preview shows document pages 1 - 12. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online